Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?

被引:0
|
作者
Melotti, Laura [1 ,2 ]
Rinaldi, Matteo [1 ,3 ]
Salice, Marco [2 ]
Dussias, Nikolas K. [1 ,2 ]
Vanigli, Nicholas [1 ,2 ]
Calabrese, Carlo [1 ,2 ]
Scaioli, Eleonora [2 ]
Gabrielli, Liliana [1 ,4 ]
Lazzarotto, Tiziana [1 ,4 ]
Rosini, Francesca [5 ]
Viale, Pierluigi [1 ,3 ]
Gionchetti, Paolo [1 ,2 ]
Giannella, Maddalena [1 ,3 ]
Rizzello, Fernando [1 ,2 ]
机构
[1] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[2] IRCCS Azienda Osped Univ Policlin St Orsola Malpig, Dept Med & Surg Sci, IBD Unit, Bologna, Italy
[3] IRCCS Azienda Osped Univ Bologna, Dept Integrated Risk Management, Infect Dis Unit, Bologna, Italy
[4] IRCCS Azienda Osped Univ Bologna, Microbiol Unit, Bologna, Italy
[5] IRCCS Azienda Osped Univ Bologna, Pathol Unit, Bologna, Italy
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
关键词
CMV colitis; inflammatory bowel diseases; colectomy; INFLAMMATORY-BOWEL-DISEASE; CYTOMEGALOVIRUS-INFECTION; REACTIVATION; PREVALENCE; DIAGNOSIS; MODERATE; RISK;
D O I
10.1128/spectrum.01159-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cytomegalovirus (CMV) colitis is a serious concern worsening the prognosis of patients with ulcerative colitis (UC). We aimed to assess risk factors and prognostic impact of CMV colitis in patients with moderate-to-severe UC flare. We conducted a retrospective, observational, single-center study. Consecutive adult patients hospitalized for moderate-to-severe UC from January 2020 to June 2023 were included. The primary endpoint was a diagnosis of CMV-colitis according to immunohistochemistry on tissue biopsies. The secondary endpoint was the need for colectomy within 30 days. Overall, 135 patients were included. CMV colitis was diagnosed in n = 37 (27.4%): n = 19 (51.4%) endoscopically, the remaining on surgical specimens. Of them, n = 23 (62.2%) had positive CMV-DNAemia with a median value of 1,008 cp/mL (interquartile range 318-2,980). Differences between the two groups (CMV colitis vs non-CMV) included age (60 vs 41 years, P = 0.004), Charlson Comorbidity Index (1 vs 0, P = 0.003), steroid refractoriness (86.5% vs 62.2%, P = 0.007), and positive CMV-DNAemia (62.2% vs 10.1%, P < 0.001). At multivariable analysis, steroid-refractory disease, Charlson Comorbidity Index, and CMV-DNAemia were associated with CMV colitis. Overall, n = 54 (39.7%) patients underwent colectomy, and this was significantly more common in patients with CMV colitis vs non-CMV group (54.1% vs 34.4%, P = 0.049). Kaplan-Meier showed that antiviral therapy seems to have a relevant impact on colectomy (P < 0.001). CMV-DNA blood detection is independently associated with CMV-positive refractory UC. Since CMV colitis may increase the risk of colectomy and antiviral treatment seems to reduce such risk, prospective studies are needed to confirm the role of CMV-DNA blood detection to early diagnose CMV colitis. IMPORTANCE Cytomegalovirus (CMV) colonic reactivation worsens the prognosis of patients with active ulcerative colitis. Blood CMV-DNA reactivation is strongly associated with CMV colitis. Prompt diagnosis and treatment of CMV colitis can avoid surgery in most cases.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Diagnostic Utility of Cytomegalovirus (CMV) DNA Quantitation in Ulcerative Colitis
    Esen, Sema
    Saglik, Imran
    Dolar, Enver
    Cesur, Selcan
    Ugras, Nesrin
    Agca, Harun
    Merdan, Osman
    Ener, Beyza
    VIRUSES-BASEL, 2024, 16 (05):
  • [22] CMV infection in severe refractory ulcerative and Crohn's colitis
    Adani, GL
    Avital, I
    Ferraresso, C
    Aoki, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (12): : 3464 - 3465
  • [23] Anti-virus treatment against CMV in patients with ulcerative colitis by the PCR monitoring for mucosal CMV-DNA
    Tanaka, M.
    Takagi, T.
    Toyokawa, Y.
    Hotta, Y.
    Uchiyama, K.
    Naito, Y.
    Itoh, Y.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S279 - S279
  • [24] CMV colitis in solid organ transplant patients
    Yildiz, Ozan
    Arslan, Hande
    Ozgun, Gonca
    Suna, Nuredtin
    Yilmaz, Ozlem
    Karakaya, Emre
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (9S)
  • [25] CMV colitis in solid organ transplant patients
    Yildiz, Ozan
    Arslan, Hande
    Ozgun, Gonca
    Suna, Nuredtin
    Yilmaz, Ozlem
    Karakaya, Emre
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (09) : 470 - 470
  • [26] Diagnosis and Management of CMV Colitis
    Anat Yerushalmy-Feler
    Jacqueline Padlipsky
    Shlomi Cohen
    Current Infectious Disease Reports, 2019, 21
  • [27] CMV Colitis in an Immunocompetent Patient
    Razavi, Mohammad
    Euliano, Rebekah
    Fantazos, Jessica
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S318 - S318
  • [28] CMV COLITIS IN AN IMMUNOCOMPETENT ADULT
    BLAIR, SD
    FORBES, A
    PARKINS, RA
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1992, 85 (04) : 238 - 239
  • [29] CMV COLITIS IN AN IMMUNOCOMPETENT PATIENT
    Lucas, Alexandria
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S428 - S428
  • [30] CMV colitis in an elderly patient
    Larkin, JA
    Li-Espino, E
    INFECTIONS IN MEDICINE, 2001, 18 (08) : 396 - 398